Clinical trial
Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
NCT01410981 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
- Lead sponsor
- Medical University of South Carolina
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2011
- Completion date
- June 30, 2014
- Enrollment
- 73 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.